|Home | About | Journals | Submit | Contact Us | Français|
The maternal uterine environment is likely critical for human placental morphogenesis and development of its different trophoblast subtypes. However, factors controlling growth and differentiation of these cells during early gestation remain poorly elucidated. Herein, we provide evidence that the ligand Wnt5a could be a critical regulator of trophoblast proliferation and survival. Immunofluorescence of tissues and western blot analyses of primary cultures revealed abundant Wnt5a expression and secretion from first trimester decidual and villous stromal cells. The ligand was also detectable in decidual glands, macrophages and NK cells. Wnt5a increased proliferation of villous cytotrophoblasts and cell column trophoblasts, outgrowth on collagen I as well as cyclin A and D1 expression in floating explant cultures, but suppressed camptothecin-induced apoptosis. Similarly, Wnt5a stimulated BrdU incorporation and decreased caspase-cleaved cytokeratin 18 neo-epitope expression in primary cytotrophoblasts. Moreover, Wnt5a promoted activation of the MAPK pathway in the different trophoblast models. Chemical inhibition of p42/44 MAPK abolished cyclin D1 expression and Wnt5a-stimulated proliferation. Compared to controls, MAPK phosphorylation and proliferation of cytotrophoblasts declined upon supplementation of supernatants from Wnt5a gene-silenced decidual or villous stromal cells. In summary, non-canonical Wnt5a signalling could play a role in early human trophoblast development by promoting cell proliferation and survival.
Rapid development of placental structures during the first weeks of gestation is critical for embryonic survival and maintenance of pregnancy. Whereas cytotrophoblast (CTB) progenitors in floating placental villi differentiate into the multinucleated syncytium, proliferative CTBs of anchoring villi give rise to extravillous trophoblasts (EVT) invading the maternal uterus. Besides a strong intrinsic molecular program generating the diverse specialized trophoblast subtypes, endocrine secretions from uterine cells are likely important for trophoblast growth and branching morphogenesis of the human placenta during the first weeks of gestation1,2. Shortly after implantation cytotrophoblasts (CTBs) of primary villi contact the decidua and expand laterally thereby forming the cytotrophoblastic shell protecting the embryo from early insults of the maternal environment such as oxidative stress3. Formations of channels through the shell connecting decidual glands with the developing intervillous space suggested that glandular secretions could be necessary for histiotrophic nutrition of the fetus as well as for early stages of trophoblast development4,5. Indeed, glandular epithelial cells of the decidua are rich in carbohydrates and lipids but also produce a variety of growth factors, such as epidermal growth factor, stimulating trophoblast proliferation in vitro6,7. At later stages of pregnancy, formation of anchoring villi, attaching to the decidua, and invasion of CTBs into uterine tissue and vessels takes place. The latter contributes to spiral artery remodeling and establishment of the haemotrophic nutrition8, and is likely controlled by diverse decidual cell types. Indeed, numerous autocrine as well as paracrine factors present at the fetal-maternal interface could regulate trophoblast proliferation, differentiation and migration9. Defects in placentation, provoking abnormal uterine vessel remodeling, trophoblast invasion and survival, were associated with different pregnancy disorders, such as miscarriage, preterm labour and preeclampsia10,11,12. Besides failures in the intrinsic EVT differentiation program, deranged uterine secretions could be an underlying cause4,13. However, the network of soluble decidual factors controlling placentation and its role in the pathogenesis of gestational diseases remain poorly understood.
Recently, the developmental Wingless (Wnt) pathway, which regulates stem cell maintenance, cell fate decisions and differentiation during embryogenesis and in adult tissues14, has also been implicated in endometrial function, implantation and placental development15. Activation of canonical Wnt signalling requires binding of secreted Wnt ligands to hetero-dimeric receptors consisting of frizzled (Fzd) family members and low-density lipoprotein receptor related protein 5 or 6 (LRP-5/6)16. As a consequence, cytosolic β-catenin is stabilized by dissolving its destruction complex and recruited to the nucleus14. Active β-catenin then binds to nuclear factors of the lymphoid enhancer binding factor-1 (LEF-1)/T-cell factor (TCF) family thereby activating transcription of genes which promote cell cycle progression, differentiation and invasion16. Whereas studies in mice indicated a role of the Wnt pathway in early trophectoderm specification, chorio-allantoic fusion, placental branching morphogenesis and labyrinth development17,18, canonical signalling in humans was shown to enhance syncytialisation of choriocarcinoma cells as well as EVT differentiation and migration19,20,21. Noteworthy, first trimester CTBs produce numerous Wnt molecules and Fzd receptors and the soluble Wnt inhibitor Dickkopf-1 (Dkk1) reduced basal trophoblast motility indicating autocrine effects20,22. On the other hand, human endometrial cells express various Wnt ligands23,24 suggesting that paracrine activation of the pathway could also regulate trophoblast development and function. However, expression patterns of Wnt ligands in the diverse decidual cell types of early pregnancy and their individual roles in the cross-talk with placental trophoblast remain largely elusive.
Among the different ligands Wnt5a might have a pivotal function in reproduction since it is required for the development of uterine glands and the posterior region of the female reproductive tract and also regulates blastocyst implantation25,26. Although Wnt5a can activate LEF-1/TCF/β-catenin-mediated transcription27, it antagonizes the canonical Wnt pathway in most cellular systems and provokes non-canonical signalling through a variety of different cascades28. Besides elevating intracellular Ca2+ concentrations29, Wnt5a was shown to activate RhoA/Rho kinase, Rac/c-Jun terminal kinase, phosphatidylinositide 3-kinase (PI3K)/AKT and mitogen-activated protein kinase (MAPK)30,31,32.
Recent evidence from our laboratory suggested that Wnt5a also suppresses canonical Wnt signalling in trophoblasts22. Since the latter pathway was associated with EVT functions19,20, we speculated that non-canonical signalling through Wnt5a could control other aspects of placental morphogenesis such as growth of villous CTBs and cell columns. Therefore, we herein investigated decidual and placental expression patterns of Wnt5a by immunofluorescence and western blotting and studied its function using different primary trophoblast models. The data suggest that Wnt5a, secreted by villous and decidual stromal cells, promotes trophoblast proliferation and survival involving activation of the MAPK pathway.
To gain first insights into the expression pattern of Wnt5a in first trimester placenta and decidua, tissue sections and purified cell populations were investigated by immunofluorescence, western blotting and RT-qPCR, respectively (Fig. 1). Wnt5a was detected in macrophages and villous stromal cells as well as in villous CTBs and the syncytium of placental sections (Fig. 1a). Immunofluorescence of decidual tissues revealed expression of the ligand in glandular epithelial cells, interstitial CTBs, stromal cells, macrophages and uterine natural killer (uNK) cells (Fig. 1b). Comparative gene expression profiling of us33 and others34 also suggested expression of Wnt5a mRNA in proliferative, epidermal growth factor receptor (EGFR)-positive CTBs and invasive, human leukocyte antigen-G-positive EVTs (not shown). However, Wnt5a transcript levels, measured by quantitative PCR, were low in first trimester CTBs compared to villous and decidual stromal cells, whereas JEG-3 did not express the ligand (Fig. 1c). Accordingly, analyses of cellular extracts indicated abundant Wnt5a protein levels in stromal cells of early pregnancy and trophoblastic SGHPL-5 cells whereas different primary CTB pools produced low amounts (Fig. 1d). Wnt5a was also detectable in purified placental and decidual CD14+ macrophages and in CD56+ decidual NK cells, but was absent from JEG-3 cells (Fig. 1d). Furthermore, Wnt5a was present in conditioned media of villous and decidual stromal cells (Fig. 1e). Quantification of western blots and adjustment to recombinant Wnt5a revealed that both stromal cell types released around 0.2ng Wnt5a per μg cellular protein per 24hours (Fig. 1e). Wnt5a secretion, however, was not affected upon in vitro differentiation of primary decidual stromal cells (Fig. 1e), which were cultivated in the presence of cAMP and/or estrogen/progesterone as previously mentioned35.
First trimester villous explant cultures and primary CTBs were treated with recombinant human (rhu) Wnt5a to assess the role of the ligand in trophoblast proliferation (Fig. 2). Immunofluorescence analyses revealed that Wnt5a increased BrdU labeling of villous CTBs and cell column trophoblasts (CCTs) in floating villous explants (Fig. 2a). Wnt5a also stimulated cyclin D1 and cyclin A protein expression in the latter (Fig. 2b). Accordingly, incubation with rhu Wnt5a increased the outgrowth distance of collagen I-seeded villous explants (Fig. 2c). Similarly, purified CTBs displayed elevated EdU incorporation (Fig. 2d) and cyclin D1 mRNA expression (Fig. 2e) in the presence of the particular Wnt ligand. Moreover, Wnt5a increased protein expression of cyclin D1 and cyclin A in these cultures (Fig. 2f). In contrast to its positive effects on trophoblast proliferation, rhu Wnt5a did not alter migration of primary CTBs through fibronectin-coated transwells (Supplementary Figure 1).
Addition of rhu Wnt5a to trophoblastic SGHPL-5 cells did not change their proliferation rate (data not shown). Since SGHPL-5 cells express high endogenous Wnt5a levels, we speculated that growth of these cells cannot be further increased by adding exogenous Wnt5a. Therefore, the effects of siRNA-mediated Wnt5a silencing on SGHPL-5 cell proliferation and cyclin D1 expressions were investigated (Fig. 3). Western blot analyses of SGHPL-5 cell extracts indicated that downregulation of Wnt5a decreased cyclin D1 expression in a time-dependent manner (Fig. 3a). Evaluation of cumulative cell numbers suggested that Wnt5a gene-silenced SGHPL-5 cells grew less efficiently (Fig. 3b). Furthermore, supplementation of rhu Wnt5a to Wnt5a siRNA-treated cultures restored cyclin D1 expression (Fig. 3c). In contrast to SGHPL-5 cells, gene silencing of Wnt5a in CTBs did not change their basal proliferation rate (data not shown).
To determine non-canonical downstream effects of Wnt5a in primary trophoblast cultures, activation of different signalling cascades was evaluated (Fig. 4). Western blot analyses of primary CTBs suggested that rhu Wnt5a induced phosphorylation of MAPK (p42/44) which could be specifically blocked in the presence of the chemical inhibitor U0126 (Fig. 4a). In contrast to ERK1/2, activation of protein kinase C (PKC) or AKT could not be observed. Accordingly, Wnt5a-stimulated MAPK phosphorylation was detected in villous CTBs and CCTs of floating villous explant cultures using immunofluorescence, whereas supplementation of U0126 inhibited ligand-induced activation of the enzyme (Fig. 4b). These data were confirmed by western blotting of whole tissue lysates isolated from the placental explants (Fig. 4c). In contrast to U0126, addition of recombinant Dkk1 did not block Wnt5a-induced ERK activation, reassuring the role of Wnt5a in non-canonical Wnt signalling of CTBs (Supplementary Figure 2). To prove that MAPK signalling is involved in Wnt5a-stimulated trophoblast proliferation, BrdU incorporation into villous CTBs and CCTs of explant cultures was studied in the absence or presence of Wnt5a and/or U0126 (Fig. 4d). Determination of the BrdU/DAPI ratio revealed that Wnt5a-induced proliferation of both vCTB and CCTs was inhibited in the presence of the chemical inhibitor. Moreover, U0126 also blocked Wnt5a-induced cyclin D1 mRNA expression in cultured CTBs (Fig. 4e).
The effects of Wnt5a treatment or siRNA-mediated downregulation of the ligand on trophoblast survival were analysed in villous explant cultures, primary CTBs and SGHPL-5 cells, respectively (Fig. 5). In floating explants rhu Wnt5a diminished camptothecin-induced expression of caspase-cleaved, cytokeratin 18 (CK18) neo-epitope, both in vCTBs and CCTs (Fig. 5a). Basal apoptosis was not significantly affected by Wnt5a in these cultures, although a trend towards lower levels could be observed. Similarly, abundance of the particular apoptotic marker decreased in campthotecin-treated primary CTBs when rhu Wnt5a was added (Fig. 5b). Accordingly, siRNA-induced gene silencing of Wnt5a in SGHPL-5 cells increased expression of cleaved caspase-3 (Fig. 5c).
To assess whether Wnt5a, secreted from decidual and villous stromal cells, exerts similar effects as the recombinant ligand, primary CTBs were incubated with supernatants obtained from Wnt5a gene-silenced cultures (Fig. 6). Western blot analyses revealed that the siRNA-treatment decreased Wnt5a protein expression in cellular extracts and supernatants of decidual and villous stromal cells, respectively (Fig. 6a). Compared to non-targeting controls, activation of p42/44 MAPK was significantly diminished when primary CTBs were stimulated with conditioned medium from Wnt5a siRNA-treated stromal cell cultures (Fig. 6b). Accordingly, BrdU labelling of CTBs was also less efficient upon incubation with supernatants from Wnt5a gene-silenced villous or decidual stromal cells (Fig. 6c).
Signalling through Wnt5a is critical for development and tumorigenesis36. During gastrulation Wnt5a is expressed in a gradient at the caudal end of the murine embryo at a time when growth and patterning of the embryonic A-P axis takes place37. Around E6.5-9.5 abundant levels of Wnt5a were detectable in different mesodermal compartments, for example in cells of the primitive streak and allantois, and later on in outgrowing embryonic structures such as limbs, genitals and face38. Homozygous mutation of Wnt5a in mice provoked truncation of tail, limbs and snout amongst other defects suggesting that the ligand is required for induction and proliferation of different mesodermal stem cells and progenitors38. In the murine endometrium, Wnt5a is also predominantly expressed in stromal cells suggesting that Wnt5a-induced mesenchymal-epithelial interactions could be crucial for proper gland formation25,39. Indeed, Wnt5a was shown to be essential for morphogenesis of the posterior female reproductive tract as well as postnatal growth of uterine glands25. Moreover, loss or overexpression of Wnt5a in the murine uterus impairs implantation, decidualization and placental branching morphogenesis indicating that regulated levels of the ligand are critical for a successful pregnancy26.
In the human reproductive tract, Wnt5a mRNA was detected in cultured endometrial epithelial and stromal cells and its expression did not change between proliferative and secretory phase of the menstrual cycle23,24. Moreover, Wnt5a protein expression was observed in isolated first and third trimester placental trophoblasts22. Therefore, the descriptive data suggested that, similar to its role in mice, human Wnt5a could also be a critical regulator of endometrial and placental development and function. To gain first insights into the putative role of Wnt5a in human placentation we herein analysed localization of the particular ligand at the fetal-maternal interface and investigated its biological role in trophoblasts. Immunofluorescence of first trimester placental and decidual tissues revealed that Wnt5a is abundant in the decidual stroma and in the core of placental villi. Accordingly, primary villous and decidual stromal cells secreted high levels of Wnt5a, whereas cultivated CTBs produced low amounts. Moreover, the ligand was also present in villous and decidual macrophages, uterine NK cells and decidual glands. Hence, Wnt5a could have multiple functions in placenta and maternal decidua involving autocrine as well as paracrine actions. Previously, macrophage-specific Wnt5a expression has been noticed in tumor-associated macrophages and upon bacterial infection which suggested a role of the ligand in inflammatory responses40,41. However, more recent data showed that Wnt5a induces an immunosuppressive macrophage phenotype and inhibits differentiation of monocytes into inflammatory M1 macrophages42. Noteworthy, alternatively activated M2-like macrophages, which are thought to confer immunogenic tolerance to the semi-allogeneic fetus43, increase in the decidua from first to second trimester44. Therefore, we speculate that Wnt5a, secreted from monocytes and stromal cells, could affect decidual macrophages thereby contributing to the generation of an immune tolerant milieu required for successful progression of pregnancy. Moreover in analogy to other developing tissues and organs, Wnt5a could play a pivotal role at the fetal-maternal interface. For example, Wnt5a has been implicated in angiogenesis promoting proliferation, migration and survival of endothelial cells and also controls differentiation of mesenchymal stem cells into different lineages31. Although we observed abundant levels of Wnt5a in primary decidual stromal cells, its expression was not regulated upon in vitro differentiation of these cultures with cAMP and estrogen/progesterone. However, proliferation of Wnt5a siRNA-treated decidual fibroblasts was slightly decreased after 5 days of cultivation (not shown), suggesting a weak autocrine effect of the ligand on uterine stromal cell growth.
According to its role in progenitor proliferation and mesenchymal-epithelial interactions in mice25,38, stimulation of the villous trophoblast epithelium could be a main function of stromal-cell derived Wnt5a. Whereas the migratory capacity of primary CTBs was not affected by the ligand, proliferation of villous CTBs and CCTs in floating explant cultures increased in the presence of exogenous rhu Wnt5a. Moreover, EdU labeling of primary CTBs was significantly enhanced. Compared to controls, conditioned media of Wnt5a gene-silenced villous or decidual stromal cells stimulated CTB growth less efficiently. Therefore, we speculate that decidua-derived Wnt5a could be a critical soluble factor promoting proliferation of proximal CCTs during the first trimester of pregnancy. On the other hand, mitotic activity of villous CTBs and proximal CCTs could be stimulated by Wnt5a released form the underlying placental mesenchyme. Autocrine effects of Wnt5a on trophoblast proliferation could not be detected, likely due to the fact that CTBs express low amounts of the ligand. In contrast, Wnt5a was abundant in the trophoblastic cell line SGHPL-5 and silencing of its mRNA consequently impaired proliferation. Interestingly, the decidual glands also express Wnt5a suggesting that glandular secretion of the factor could support trophoblast growth and placental branching morphogenesis during the period of histiotrophic nutrition and early placental development. Along those lines, the placental spongiotrophoblast layer of mice with uterine loss of Wnt5a was smaller at E12 compared to wildtype animals corroborating a critical role of the ligand in trophoblast proliferation and/or survival26. Non-canonical Wnt signalling through Wnt5a is complex and involves numerous pathways and receptors28,31. In the planar cell polarity (PCP)/convergent extension pathway Wnt5a was shown to promote cell movements during gastrulation involving activation of RhoA/Rho kinase and Rac/c-Jun terminal kinase31. Wnt5a can also increase intracellular Ca2+ levels by release from internal stores thereby activating protein kinase C and calcium/calmodulin-dependent protein kinase II29. The particular pathway, which is also elicited by Wnt11, controls cell fate decisions and differentiation29. However, it is unlikely that Wnt5a triggers Wnt/Ca2+ signalling in human CTBs since activation of protein kinase C could not be observed. Moreover, Wnt5a can also induce signalling through PI3K/AKT, MAPK or nuclear factor κB (NFκB) controlling many different cellular functions such as proliferation, differentiation, migration or inflammation30,32. Whereas the ligand did not affect AKT, phosphorylation of p42/44 MAPK (ERK1/2) was noticed in Wnt5a-treated villous explant cultures and primary CTBs. Chemical inhibition with U0126 did not only block paracrine activation of the enzymes by exogenously added Wnt5a, but also reduced ligand-induced proliferation of vCTBs and CCTs in explant cultures as well as cyclin D1 expression. Therefore, the data suggest that ERK1/2 are critical for the Wnt5a-stimulated mitotic activity of placental trophoblasts.
Besides controlling CTB proliferation Wnt5a could also promote trophoblast survival since treatment with the recombinant ligand inhibited camptothecin-induced apoptosis. Wnt5a-dependent survival involves the expression of pro-survival genes in other cellular systems, mediated by signalling through protein kinase A/cAMP response element-binding protein (CREB), PI3K/Akt, NFκB or p42/44 MAPK30,45,46. Since the latter pathway triggers CTB proliferation, we speculate that it could also play a role in inhibiting trophoblast apoptosis. In contrast to primary CTBs, the function of Wnt5a is altered in tumorigenic trophoblasts since treatment of JAR cells with the ligand increased apoptosis and suppressed proliferation47. These data support the common view that Wnt5a functions highly depend on the cellular context and the specific expression patterns of its receptors.
Indeed, Wnt5a may exert its effects on trophoblasts through different receptor complexes. Wnt5a was shown to activate several different Fzd members, i.e. Fzd2, Fzd3, Fzd4, Fzd5 and Fzd8 in a canonical or non-canonical fashion, of which Fzd5 is the most abundant receptor in first trimester CTBs22. In mice, homozygous mutation of Fzd5 affected angiogenesis in the placenta and yolk sac48. Moreover, a recent study indicated that Wnt signalling through Fzd5 is essential for placental morphogenesis promoting maintenance of glial cells missing 1 (GCM1) expression at distinct branching sites49. Interestingly, gene expression profiles published by us and others33,34 suggested that Fzd5 mRNA is strongly expressed in non-invasive CTBs but largely absent from EVTs (not shown). The differential expression of Fzd5 might explain why EVT migration could not be stimulated by Wnt5a. On the other hand, Wnt5a also signals through the receptor tyrosine kinase Ror2 which can bind the ligand on its own or act as Fzd co-receptor36. Of note, Wnt5a-Ror2 signalling was shown to provoke activation of p24/44 MAPK50, which lets us speculate that this pathway could also play a role in CTB proliferation. Moreover, since transactivation of the EGFR by Wnt5a has been noticed51,52, it is possible that the ligand also stimulates p42/44 MAPK phosphorylation through EGFR-Ras-Raf-MEK-ERK signalling. Further investigations are needed to clarify the full network of Wnt5a receptors and their downstream signalling cascades in first trimester CTBs.
In summary, the present data suggest that Wnt5a, secreted by different decidual and placental cell types, could be a critical regulator of human placentation and trophoblast function (Fig. 7). Besides controlling proliferation though p42/44 MAPK activation, it also promotes survival of CTBs. Moreover, the pivotal role of Wnt5a during reproductive development and its abundance at the fetal-maternal interface suggest that the ligand could eventually regulate numerous processes in human placenta and decidua such as angiogenesis, stromal cell growth, macrophage differentiation and immunomodulation.
Placental and decidual tissues (6–13 weeks of gestation, n=88) were obtained from elective pregnancy terminations. Utilization of tissues and all experimental procedures were approved by the ethical committee of the Medical University of Vienna. Methods were carried out in accordance with the approved guidelines. Written informed consent was obtained from all subjects.
SGHPL-5 cells were cultivated in DMEM/Ham’s F-12 (1:1) (Gibco BRL Life Technologies, Paisley, UK) supplemented with 0.05mg/ml gentamicin (Gibco) and 10% fetal calf serum (FCS) (Biochrom AG, Berlin, Germany) as mentioned53.
First trimester CTBs were isolated by Percoll gradient centrifugation from pooled placentae (n=4–7) as described54,55 and plated (40minutes) in culture medium (DMEM/Ham’s F-12/10% FCS/0.05mg/ml gentamicin/0.5μg/ml fungizone, Gibco) allowing for adherence of contaminating stromal cells. CTBs were seeded onto fibronectin-coated dishes (2.5×105 cells/cm2) in culture medium and characterised by immunofluorescence using cytokeratin 7 (KRT7, OV-TL12/30, 1.96μg/ml; Dako, Glostrup, Denmark) and vimentin (VIM; SP20, Abcam, 1:100) antibodies. Alexa Fluor 488 (goat anti-mouse) and Alexa Fluor 568 (goat anti-rabbit) were used as secondary antibodies (2μg/ml, Molecular Probes, Invitrogen), respectively. Vimentin-positive cells were less than 1%.
To isolate placental macrophages, villi were digested twice in 0.125% trypsin (Gibco)/0.5mg/ml DNAse I (Sigma Aldrich)/25mM HEPES diluted in 1xHanks’ balanced salt solution under agitation for 15min at 37°C and enriched by Percoll gradient centrifugation. Macrophages were purified by positive selection using anti CD14 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany).
Villous stromal cells were cultivated by seeding trypsin digested and Percoll gradient centrifugation enriched placental villi as described onto plastic cell culture dishes for 40minutes54,55. Non adhering cells were removed and cell culture dishes were overlaid with fresh culture medium. As soon as cells reached confluency they were split and used for further experiments.
Decidua basalis tissues (7–12 week n=6) were used to isolate stromal and uNK cells as mentioned56,57. Briefly, small pieces of tissues (3mm2) were digested 3 times for 20minutes under agitation using collagenase I (2mg/ml, Gibco) and DNAse I (0.5mg/ml Sigma). For cultivation of decidual fibroblasts cells were filtered over a 70μm cell strainer and seeded in the above mentioned cell culture medium. For in vitro decidualization cells were treated with of cAMP and estrogen/progesterone35. Decidual NK cells were isolated from the non-adherent cell population of plated decidual stromal cells by positive selection with CD56-PE antibodies and Anti-PE MicroBeads (MACS Miltenyi Biotec) 20hours after plating. Decidual macrophages were purified using anti CD14 MicroBeads, directly after digestion of tissues.
First trimester placental and decidual tissues (6th–12th week, n=15) were fixed in paraformaldehyde and embedded in paraffin. Serial sections (3μm) were analysed by immunofluorescence as described58. Primary antibodies were as follows: Wnt-ligand 5a (Wnt5a; 3A4; LSBio; 1:300), Vimentin (Vim 3B4, Dako, 1:100), Cytokeratin wide spectrum (PanKRT) (GeneTex; 1:100), Cytokeratin 7 and Vimentin (both mentioned above), CD14 (Atlas Antibodies, 1:200), CD56 (123C3, Cell Signaling, 1:50), Bromodeoxyuridine (BrdU; Bu20a, Dako, 26μg/ml), hepatocyte growth factor activator inhibitor 1 (HAI-1; H-108, Santa Cruz, 1:100), cytokeratin 18 neo-epitope (M30 CytoDEATH, Roche, 1:100) and phospho-p44/p42 MAPK (Erk1/2) (Thr202/Tyr204) (D13.14.4E XP, Cell Signaling 1:200). Samples were incubated for one hour with 2μg/ml of secondary antibody Alexa Fluor 488 (goat anti-mouse), Alexa Fluor 488 (goat anti-rabbit), Alexa Fluor 546 (goat anti-mouse) or Alexa Fluor 568 (goat anti-rabbit). Nuclei were stained with DAPI (1μg/ml, Roche, Mannheim, Germany). Slides were analysed by fluorescence microscopy (Olympus BX50, Cell^P software) and digitally photographed.
Gene silencing using a mixture of 4 different siRNAs targeting Wnt5a or a non-targeting (ntc) control pool (L-003939-00-0005 and D-001810-10-20 ON-TARGETplus SMARTpools, Dharmacon-Thermo Fisher Scientific, MA) was performed as published59. Wnt5a-gene silenced SGHPL-5 cells were used 5, 24, 48 or 72hours post siRNA delivery. Primary villous and decidual stromal cells were passaged once after isolation before siRNAs were added. Cellular extracts and supernatants were collected 5 days after treatment.
RNA was isolated with PeqGold Trifast (Peqlab, Wilmington, DE, USA). Reverse transcription and quantitative real-time PCR (in duplicates) were performed using the 7500 Fast Real-time PCR system (Applied Biosytems) and TaqMan Gene Expression Assays CCND1 (ABI # Hs00277039_m1) and Wnt5a (ABI #Hs00998537_m1) as described35. 1μl cDNA, 0.5μl primers and 5μl Fast 2x PCR-Mix (TaqMan Universal PCR Master Mix) were used per sample. Signals (ΔCt) were normalized to TATA-box binding protein (TBP, ABI # 4333769F). Relative expression levels were determined by using values of controls as a calibrator (ΔΔCt).
Protein extracts were separated on SDS/PAA gels, transferred onto Amersham Hybond-P PVDF membranes and incubated with primary antibodies as mentioned19. The following antibodies were used: Wnt5a (C27E8, Cell Signaling, 1:1000), GAPDH (14C10, Cell Signaling 1:5000), α-tubulin (Calbiochem DM1A, 1:5000), actin (Sigma 1:2500) CCNA (clone 6E6, Thermo Scientific, 1:100), CCD1 (DSC-6 Santa Cruz 1:500) CD14 (Atlas Antibodies, HPA001887, 1:200) CD56 (123C3, Cell Signaling 1:1000), phospho-p44/p42 MAPK (ERK1/2) (Thr202/Tyr204) (D13.14.4E XP, Cell Signaling, 1:1000), p44/42 MAPK (ERK1/2) (Cell Signaling, 1:1000), phospho-PKC (pan) (βII Ser660) (Cell Signaling, 1:1000), phospho-AKT (Ser473) (D9E XP, Cell Signaling 1:1000), caspase-cleaved cytokeratin 18 neo-epitope (M30 CytoDEATH, Roche, 1:500), cleaved caspase-3 (Asp175) (5A1E, Cell Signaling, 1:1000). Subsequently, membranes were incubated for 1hour with HRP-conjugated secondary antibodies (goat anti-mouse, Sigma, 1:50.000, or anti-rabbit, Cell Signaling, 1:5000). Signals were developed using ECL prime detection Kit (GE Healthcare) and visualized with FluorChemQ imaging system (Alpha Innotech, San Leandro, USA). Quantification was performed by Image J software.
5×104 SGHPL-5 cells, seeded in duplicates, were treated with ntc or Wnt5a siRNAs. Cell numbers were counted at 5, 24, 48 and 72hours using Casy cell counting system (Casy1 Model TTC, Schärf System). Proliferation of primary CTBs was analysed by EdU Cell Proliferation assay EdU-Click 488 (base click, Tutzing, Germany). Cells were seeded onto fibronectin-coated 48 wells (duplicates), treated with rhu Wnt5a (500ng/ml, R&D Minneapolis, USA) or supernatants of decidual or villous stromal cells (diluted 1:2 in cell culture medium), and 1μM EdU (5-ethynyl-2′-deoxyuridine) was added for 20hours. After fixation colour development was performed and CTBs were stained with cytokeratin 7 antibodies as mentioned above. Five immunofluorescence pictures were taken per condition using an EVOS FL Color Imaging System (100 fold magnification). Proliferation was quantified as the percentage of EdU positive-nuclei of KRT7-positive CTBs. Moreover, 12–15 villous explants of different placentae (7–9th week) were cut into equivalent pieces and separated into treatment groups, incubated with vehicle (0.1% bovine serum albumin) or rhu Wnt5a overnight. Bromodeoxyuridine (BrdU, Roche, 1μM) was added for additional 4hours. After fixation and embedding, BrdU incorporation was detected by immunofluorescence. Proliferation was quantified as the percentage of BrdU-labelled nuclei of HAI-1-positive CTBs. 1500–2500 CTBs and CCT nuclei were evaluated. To investigate the role of ERK1/2, villous explants were pre-treated with 10μM U0126 before supplementation of Wnt5a and BrdU for 24h.
16 villous explants of pooled placentae (n=4–6; 7–9th week) were dissected per condition and, seeded onto rat tail collagen I as mentioned60 and treated with rhu Wnt5a. Outgrowth area was digitally photographed using the EVOS FL Color Imaging System. Outgrowth distance was quantified after 48h of cultivation by measuring the distance from the villous tip to the migratory front using Adobe Photoshop CS5 (3 measurements per explant).
Primary trophoblasts were serum-starved (2hours) followed by treatment with cell culture medium for 1hour and incubation with 10μM U0126 and/or rhu Dkk1 (1μg/ml R&D) for 1h. Rhu Wnt5a or 0.1% bovine serum albumin (control) were added for 20minutes before protein extracts were prepared. Additionally, serum-starved CTBs were treated with culture medium for 3hours and subsequently stimulated with Wnt5a-depleted stromal cell supernatants (diluted 1:2 in medium) for additional 20minutes. To study ERK activation in floating villous explant cultures, 12–15 placental explants of pooled placentae (n=3–6, 7–8th week) and condition were dissected, incubated with 10μM U0126 for 30min and treated with rhu Wnt5a for 1.5hours, followed by immunofluorescence or western blotting.
Fibronectin-seeded primary CTBs were treated with Wnt5a or 0.1% BSA for 30minutes before 0.5μM camptothecin (CPT, MP Biomedicals Santa Ana CA, USA) was added for 24hours. Cells were lysed and analysed by western blotting detecting caspase-cleaved cytokeratin 18 (CK18 neo-epitope). Also, 12–15 explants of pooled placentae (n=4–7; 7–8th week) were incubated with rhu Wnt5a for 30minutes before camptothecin (0.5μM) was supplemented for 20hours. Tissues were analysed by immunofluorescence using antibodies against caspase-cleaved cytokeratin 18 (CK18 neo-epitope), HAI-1 and DAPI as mentioned above. Apoptotic trophoblasts were quantified as the ratio of CK18 neo-epitope-positive nuclei to HAI-1 positive vCTBs and CCTs. 1500-2500 cells were counted. Additionally, apoptosis was evaluated in Wnt5a-gene silenced SGHPL-5 cells detecting cleaved caspase-3 in western blots.
Migration of primary CTBs through fibronectin-coated transwells were performed in the presence of rhu Wnt5a or rhu EGF (25ng/ml) as recently described19. Undersides of filters were stained with KRT7 antibodies and DAPI. After mounting KRT7-positive CTBs with DAPI-positive nuclei were counted. Five non-overlapping pictures of each membrane representing approximately 40–50% of the overall surface were taken and analysed using ImageJ.
Statistical analyses were performed with Student’s unpaired t-test or Mann-Whitney U test using SPSS 14 (SPSS Inc.). Gaussian distribution and equality of variances were examined with Kolmogorov-Smirnov test and Levene Test, respectively. For multiple comparisons One-Way ANOVA and appropriate post-hoc tests were performed. A P value of <0.05 was considered statistically significant.
How to cite this article: Meinhardt, G. et al. Wingless ligand 5a is a critical regulator of placental growth and survival. Sci. Rep. 6, 28127; doi: 10.1038/srep28127 (2016).
The present study was funded by a grant from the Herzfelder’sche Familienstiftung, Vienna, Austria. Gerlinde R. Otti and P. Velicky were supported by grant P-25187-B13 and P-28417-B30, respectively, of the Austrian Science Funds, Vienna, Austria. We thank G. Whitley, UK, for providing SGHPL-5 cells.
Author Contributions G.M. performed the majority of research experiments. S.H., G.R.O. and P.V. were involved in preparing primary cell culture of trophoblast and decidual cells. L.S. performed statistical analyses. C.F. collected material and informed patients. J.P. prepared figures and revised the manuscript. M.K. designed the experiments, interpreted the data and wrote the manuscript.